ClinicalTrials.gg
CompletedNCT04632875Updated Jun 14, 2021

Online Trial of Meditation and Behavior

An interventional study of Loving-Kindness Meditation and Relaxation Meditation in Meditation, sponsored by Georgetown University. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-14.

Sponsored by Georgetown University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

This study investigates how different types of meditation may affect behaviors and emotions. The study is conducted entirely online and involves listening to 4-weeks of a guided meditation training. The meditation involves either Loving-Kindness or Relaxation techniques. The purpose of the study is to assess changes in behaviors and emotions using standard questionnaires, reports of real-world behavior, and online behavioral tasks. The overarching goal is to help clarify how mind-body practices may improve some aspects of well-being.

02

Conditions studied

  • Meditation
03

In context

Lead sponsor

Georgetown University is the lead sponsor of 291 studies on the registry; 41 are open to participants now.

Of its 28 completed or terminated interventional studies of FDA-regulated products, 20 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Is a medically healthy individual
  • Lives in the United States
  • Has reliable internet access and the ability to join a Zoom video chat

Exclusion criteria

Exclusion Criteria:

  • Has experience with meditation or other mind-body practices
  • Has a neurological disease
  • Has a current psychiatric disorder
  • Is on medication that affects the central nervous system (e.g. psychotropic drugs)
  • Has recurrent or chronic pain
  • Is pregnant or planning to become pregnant
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
75 participants (actual)

Study arms

  • Experimental
    Loving-Kindness Meditation

    4-week guided Loving-Kindness Meditation training (administered online).

    Behavioral: Loving-Kindness Meditation

  • Experimental
    Relaxation Meditation

    4-week guided Relaxation Meditation training (administered online).

    Behavioral: Relaxation Meditation

Interventions

  • BehavioralLoving-Kindness Meditation

    Approximately 15-minute sessions are administered 6 days per week

    Also known as: Metta Meditation

  • BehavioralRelaxation Meditation

    Approximately 15-minute sessions are administered 6 days per week

    Also known as: Progressive Muscle Relaxation

06

What researchers measure

Primary outcomes

  1. Social functioning

    Participants will complete a questionnaire about their real-world social behaviors. An aggregate score will be computed; higher scores will indicate better social functioning.

    Time frame: 4-5 weeks

  2. Affective responses

    Participants will perform a wall-sit test and responses will be measured using a 0-100 Visual Analog Scale of intensity.

    Time frame: 4-5 weeks

Secondary outcomes

  1. Psychological well-being related to COVID-19

    Participants will complete a questionnaire related to the psychological impact of COVID-19 social distancing. Higher scores will indicate worse psychological impact of COVID-19.

    Time frame: 4-5 weeks

07

Study locations

1 site
  • Georgetown University
    Washington D.C., District of Columbia 20007, United States
08

References and documents

Publications

  • Young O, O'Connell K, Nero N, Somers MC, Freeburg PA, Dutton MA, Marsh AA. Assessing the effect of Loving-Kindness Meditation on pain and social well-being using a randomized controlled trial design. PLoS One. 2026 Sep 16;21(9):e0357888. doi: 10.1371/journal.pone.0357888. eCollection 2026. PubMed 42748179 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 14, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04632875
Responsible party
Sponsor
First posted
Nov 17, 2020
Start date
Dec 4, 2020
Primary completion
Jun 10, 2021
Completion
Jun 10, 2021
Last update
Jun 14, 2021

Study contacts

Abigail A Marsh, PhD
principal investigator · Georgetown University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion